Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maingon

Showing results (301-310 of 340) with videos related to

Pageof 34
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Prostatic cancers]Michel Soulié, Philippe Beuzeboc, François Cornud, et al.
The Lancet. Oncology|January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98Christian Carrie, Jacques Grill, Dominique Figarella-Branger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2019
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicityVéronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2009
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)Vincenzo Valentini, Cynthia Aristei, Bengt Glimelius, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2010
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trialVéronique Beckendorf, Stéphane Guerif, Elisabeth Le Prisé, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2005
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocolChristian Carrie, Xavier Muracciole, Frédéric Gomez, et al.
Pageof 34

Showing results (301-310 of 340) with videos related to

Sort By:
Pageof 34
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Prostatic cancers]Michel Soulié, Philippe Beuzeboc, François Cornud, et al.
The Lancet. Oncology|January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Gilles Calais, Laurent Mineur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98Christian Carrie, Jacques Grill, Dominique Figarella-Branger, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2019
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)Eleonor Rivin Del Campo, Oscar Matzinger, Karin Haustermans, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicityVéronique Beckendorf, Stéphane Guérif, Elisabeth Le Prisé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2009
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)Vincenzo Valentini, Cynthia Aristei, Bengt Glimelius, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2010
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trialVéronique Beckendorf, Stéphane Guerif, Elisabeth Le Prisé, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 2005
Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocolChristian Carrie, Xavier Muracciole, Frédéric Gomez, et al.
Pageof 34